Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
THE DECLINE IN GASTRIC CANCER: EPIDEMIOLOGY OF AN UNPLANNED TRIUMPH
Countries citing papers authored by Ernst L. Wynder
Since
Specialization
Citations
This map shows the geographic impact of Ernst L. Wynder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ernst L. Wynder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ernst L. Wynder more than expected).
This network shows the impact of papers produced by Ernst L. Wynder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ernst L. Wynder. The network helps show where Ernst L. Wynder may publish in the future.
Co-authorship network of co-authors of Ernst L. Wynder
This figure shows the co-authorship network connecting the top 25 collaborators of Ernst L. Wynder.
A scholar is included among the top collaborators of Ernst L. Wynder based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Ernst L. Wynder. Ernst L. Wynder is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
El‐Bayoumy, Karam, Pramod Upadhyaya, Dhimant Desai, et al.. (1996). Effects of 1,4-phenylenebis(methylene)selenocyanate, phenethyl isothiocyanate, indole-3-carbinol, and d-limonene individually and in combination on the tumorigenicity of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in A/J mouse lung.. PubMed. 16(5A). 2709–12.39 indexed citations
Wynder, Ernst L., Mario Orlandi, & Mary Boyle. (1984). The American Health Foundation guide to lifespan health : a family program for physical and emotional well-being.1 indexed citations
Hill, Peter, et al.. (1982). Response to luteinizing releasing hormone, thyrotrophic releasing hormone, and human chorionic gonadotropin administration in healthy men at different risks for prostatic cancer and in prostatic cancer patients.. PubMed. 42(5). 2074–80.5 indexed citations
10.
Wynder, Ernst L.. (1978). The epidemiology of cancers of the upper alimentary and upper respiratory tracts.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 88(1 Pt 2 Suppl 8). 50–1.9 indexed citations
11.
Chen, Chi hong B., G. David McCoy, Stephen S. Hecht, Dietrich Hoffmann, & Ernst L. Wynder. (1978). High pressure liquid chromatographic assay for alpha hydroxylation of N-nitrosopyrrolidine by isolated rat liver microsomes.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 38(11 Pt 1). 3812–6.19 indexed citations
Wynder, Ernst L.. (1976). Nutrition and cancer.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 35(6). 1309–15.8 indexed citations
15.
Hill, Peter, et al.. (1976). Plasma hormone profiles in populations at different risk for breast cancer.. PubMed. 36(6). 1883–5.10 indexed citations
16.
Wynder, Ernst L.. (1975). Status of Research on Nutrition and Cancer: Concluding Remarks. Cancer Research. 35. 3548–3550.2 indexed citations
17.
Wynder, Ernst L. & Dietrich Hoffmann. (1967). Tobacco and tobacco smoke : studies in experimental carcinogenesis. Academic Press eBooks.175 indexed citations
Wynder, Ernst L. & Frank R. Lemon. (1958). Cancer, coronary artery disease and smoking: a preliminary report on differences in incidence between Seventh-day Adventists and others.. PubMed. 89(4). 267–72.21 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.